NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Incorrect. It looks like what they could have said is we’ll wait to see if:

1. You get two approvals.
2. The combo trial is obvious.
3. Flaskworks commercial version is ready to test.

Discussions weren’t just talked about at the June 2024 ASM, this was waiting MAA “cement to cure” 21 months prior, at the December 2022 ASM. I don’t consider forward looking statements on collaboration/partnering potential discussions to be a joke.

So actually, while the Prometheus timeline can be instructive, it seems to me they should be way ahead of that timeline.

Prometheus had a limited oncology pipeline, whereas NWBO’s is broad spectrum. Prometheus’ most promising product was in a 2b trial. DCVax-l is nearly commercialized.